Research graph
References from Tumor stiffness creates a ferroptotic Achilles’ heel through YAP–SKP2 signaling. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.cell.2009.10.027
10.1016/j.cell.2009.10.027 · External reference
10.3390/cancers14041049
10.3390/cancers14041049 · External reference
10.3389/fonc.2018.00337
10.3389/fonc.2018.00337 · External reference
10.1093/jnci/djm135
10.1093/jnci/djm135 · External reference
Extracellular cell matrix stiffness-driven drug resistance of breast cancer cells via EGFR activation
10.1016/j.mbm.2023.100023 · 2023 · External reference
Mechanical properties of human tumour tissues and their implications for cancer development
10.1038/s42254-024-00707-2 · 2024 · External reference
10.1002/jcb.27681
10.1002/jcb.27681 · External reference
10.1038/nature04695
10.1038/nature04695 · External reference
Matrix stiffness-driven cancer progression and the targeted therapeutic strategy
10.1016/j.mbm.2023.100013 · 2023 · External reference
10.1038/nrc3080
10.1038/nrc3080 · External reference
10.1126/scitranslmed.3010467
10.1126/scitranslmed.3010467 · External reference
10.1091/mbc.e18-05-0319
10.1091/mbc.e18-05-0319 · External reference
10.1186/s13046-025-03297-8
10.1186/s13046-025-03297-8 · External reference
10.1073/pnas.1714282115
10.1073/pnas.1714282115 · External reference
10.1016/j.cell.2012.03.042
10.1016/j.cell.2012.03.042 · External reference
10.1155/2021/9929687
10.1155/2021/9929687 · External reference
10.3390/ijms21228765
10.3390/ijms21228765 · External reference
DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway
10.1038/s41388-021-01676-x · 2021 · External reference
10.1038/s41422-020-00441-1
10.1038/s41422-020-00441-1 · External reference
Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy
10.1016/j.bbagen.2017.05.019 · 2017 · External reference
Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer
10.1126/scitranslmed.adg3049 · 2023 · External reference
10.1016/j.ccell.2019.04.002
10.1016/j.ccell.2019.04.002 · External reference
10.1083/jcb.202105043
10.1083/jcb.202105043 · External reference
10.1172/jci190215
10.1172/jci190215 · External reference
NINJ1 regulates ferroptosis via xCT antiporter interaction and CoA modulation
10.1038/s41419-024-07135-1 · 2024 · External reference
10.1016/j.celrep.2019.07.107
10.1016/j.celrep.2019.07.107 · External reference
10.1038/nature10137
10.1038/nature10137 · External reference
10.1126/science.1240104
10.1126/science.1240104 · External reference
10.1038/nnano.2012.167
10.1038/nnano.2012.167 · External reference
Nanomechanical properties of solid tumors as treatment monitoring biomarkers
10.1016/j.actbio.2022.10.021 · 2022 · External reference
FIN56, a novel ferroptosis inducer, triggers lysosomal membrane permeabilization in a TFEB-dependent manner in glioblastoma
10.7150/jca.58500 · 2021 · External reference
Carboplatin/Paclitaxel Induction in Ovarian Cancer: The Finer Points
2018 · External reference
10.1016/j.redox.2019.101328
10.1016/j.redox.2019.101328 · External reference
10.1158/1541-7786.mcr-20-0534
10.1158/1541-7786.mcr-20-0534 · External reference
Verteporfin inhibits YAP function through up-regulating 14-3-3sigma sequestering YAP in the cytoplasm
2016 · External reference
10.3389/fonc.2018.00055
10.3389/fonc.2018.00055 · External reference
10.1158/0008-5472.sabcs-4167
10.1158/0008-5472.sabcs-4167 · External reference
10.1073/pnas.081474898
10.1073/pnas.081474898 · External reference
10.1002/med.21675
10.1002/med.21675 · External reference
10.1186/bcr2122
10.1186/bcr2122 · External reference
10.1186/1741-7007-8-153
10.1186/1741-7007-8-153 · External reference
10.1182/blood-2007-09-112904
10.1182/blood-2007-09-112904 · External reference
10.1093/nar/gkz430
10.1093/nar/gkz430 · External reference
10.1016/j.csbj.2021.07.014
10.1016/j.csbj.2021.07.014 · External reference
10.1038/s41587-020-0546-8
10.1038/s41587-020-0546-8 · External reference
10.1038/s41563-020-0615-x
10.1038/s41563-020-0615-x · External reference
10.1038/s41586-018-0444-0
10.1038/s41586-018-0444-0 · External reference
Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis
10.1038/s41401-022-01010-5 · 2023 · External reference
10.1172/jci166647
10.1172/jci166647 · External reference
10.1038/s41591-018-0009-7
10.1038/s41591-018-0009-7 · External reference
10.1038/s41589-020-0501-5
10.1038/s41589-020-0501-5 · External reference
10.1038/s41467-021-25934-4
10.1038/s41467-021-25934-4 · External reference
Matrix stiffness-dependent PD-L2 deficiency improves SMYD3/xCT-mediated ferroptosis and the efficacy of anti-PD-1 in HCC
10.1016/j.jare.2024.08.021 · 2025 · External reference
10.1146/annurev.biophys.050708.133724
10.1146/annurev.biophys.050708.133724 · External reference
10.1016/j.biomaterials.2014.03.081
10.1016/j.biomaterials.2014.03.081 · External reference
10.1038/s41568-019-0238-1
10.1038/s41568-019-0238-1 · External reference
10.1038/s41573-022
10.1038/s41573-022 · External reference
10.3791/52643
10.3791/52643 · External reference
10.1016/j.cell.2014.06.004
10.1016/j.cell.2014.06.004 · External reference
